Free Trial
OTCMKTS:BPMUF

Basilea Pharmaceutica (BPMUF) Stock Price, News & Analysis

Basilea Pharmaceutica logo
$47.50 0.00 (0.00%)
As of 05/30/2025

About Basilea Pharmaceutica Stock (OTCMKTS:BPMUF)

Key Stats

Today's Range
$47.50
$47.50
50-Day Range
$47.50
$54.00
52-Week Range
$47.50
$54.00
Volume
N/A
Average Volume
55 shs
Market Capitalization
$625.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.

Receive BPMUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Basilea Pharmaceutica and its competitors with MarketBeat's FREE daily newsletter.

BPMUF Stock News Headlines

Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.
See More Headlines

BPMUF Stock Analysis - Frequently Asked Questions

Basilea Pharmaceutica's stock was trading at $52.83 at the start of the year. Since then, BPMUF stock has decreased by 10.1% and is now trading at $47.50.
View the best growth stocks for 2025 here
.

Basilea Pharmaceutica subsidiaries include Conec UK Limited.

Shares of BPMUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/31/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BPMUF
CIK
N/A
Employees
147
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$175.50 million
Cash Flow
$1.02 per share
Price / Cash Flow
46.75
Book Value
($0.94) per share
Price / Book
-50.53

Miscellaneous

Free Float
N/A
Market Cap
$625.58 million
Optionable
Not Optionable
Beta
0.47

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:BPMUF) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners